Welcome to our dedicated page for Astera Labs SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astera Labs filings document a Nasdaq-listed semiconductor connectivity company serving rack-scale AI infrastructure. The company’s Form 8-K reports cover quarterly and annual operating results, product and demand commentary tied to PCIe 6, Scorpio smart fabric switches, signal conditioning and Smart Cable Modules, and material business updates.
ALAB regulatory disclosures also record its common stock listing on the Nasdaq Global Select Market, emerging growth company status, executive officer appointments and compensation arrangements, and material definitive agreements, including customer-linked warrant terms. Proxy materials describe annual meeting proposals, board elections, auditor ratification, executive compensation votes and stockholder voting mechanics.
ALAB insider filing reports a planned resale of 2,500 RSUs and discloses a prior sale of 7,500 common shares on 03/05/2026 for $898,471.75. The Form 144 lists the RSUs as issuer-originated with an intended sale date of 02/15/2026.
Astera Labs, Inc. Chief Financial Officer Desmond Lynch filed an initial ownership report on Form 3. The filing shows he beneficially owns 0 shares of Astera Labs common stock directly following this reporting event. This is a routine disclosure of insider ownership required for company officers.
Astera Labs, Inc. director Jack R. Lazar reported selling a total of 7,500 shares of common stock in open-market transactions on March 5, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025.
The weighted average sale prices ranged from about $117.64 to $123.50 per share across multiple trades. After these transactions, Lazar directly holds 87,351 shares of Astera Labs common stock.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara reported open-market sales of 10,000 shares of common stock on March 2, 2026. The transactions were carried out in multiple tranches at weighted average prices ranging from about $113.37 to $120.99 per share.
The filing notes that all sales occurred automatically under a pre-established Rule 10b5-1 trading plan adopted on May 29, 2025, which is designed to systematically execute trades over time. Following these sales, Mazzara directly owns 128,084 shares of Astera Labs common stock.
Astera Labs reports rapid expansion and a move to profitability, highlighting both opportunity and risk. Revenue grew from $115.8 million in 2023 to $396.3 million in 2024 and $852.5 million in 2025, while net income reached $219.1 million after prior-year losses. The company focuses on semiconductor-based connectivity for cloud and AI infrastructure, with products like Aries PCIe/CXL retimers, Taurus Ethernet modules, Leo CXL memory controllers, and Scorpio fabric switches, all tied together by its COSMOS software suite. Growth is heavily concentrated: in 2025, one end customer generated more than 70% of revenue and the top three end customers 86%. As of June 30, 2025, non‑affiliate common stock held a $13.2 billion market value at $90.42 per share, and 170,214,503 shares were outstanding on January 31, 2026. Management flags key risks including AI adoption uncertainty, reliance on TSMC and a small set of manufacturing partners, exposure to U.S.–China trade and export controls, cybersecurity threats, and intense competition from larger chipmakers.
Astera Labs, Inc. Chief Executive Officer Mohan Jitendra reported automatic sales of 94,971 shares of common stock on February 17, 2026. The filing states these shares were sold to satisfy tax withholding obligations tied to the vesting of previously granted restricted stock units under a pre-arranged “sell to cover” election, and it notes the transactions were not discretionary trades by the reporting person.
After these sales, Jitendra continues to hold 1,452,739 shares of common stock directly. The filing also reports additional indirect holdings through a living trust and several estate-planning trusts, for which he disclaims beneficial ownership except to the extent of any pecuniary interest.
Astera Labs, Inc. President and COO Gajendra Sanjay reported open-market sales of 94,971 shares of common stock on February 17, 2026. The shares were sold at weighted-average prices between $122.1576 and $126.3400 per share.
According to the disclosure, these shares were required to be sold to satisfy tax withholding obligations tied to vesting and settlement of previously granted restricted stock units, under a pre-arranged “sell to cover” election, and do not represent discretionary trades by Sanjay.
After these sales, he holds 1,531,301 shares directly. Estate-planning trusts associated with him hold an additional 5,864,213 shares in Trust 1, 695,000 shares in Trust 2, and 695,000 shares in Trust 3, for which he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. Chief Financial Officer Michael Truett reported automatic sales of 12,001 shares of common stock on February 17, 2026 to satisfy tax withholding from vested restricted stock units under a pre-arranged sell-to-cover election. Sale prices ranged around $122–$126 per share. Truett continues to hold 192,083 shares directly, while 450,281 additional shares are held by the Tate 1997 Living Trust, for which he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara reported automatic sales of 4,849 shares of common stock on February 17, 2026. The Form 4 notes these open-market sales were made solely to cover tax withholding obligations from vesting restricted stock units. After these transactions, he directly held 138,084 shares of common stock.